Clinical trial
Human Chorionic Gonadotropin (hCG) Trend After Medication Abortion: A Prospective Physiologic Study
NCT02179944 is registered in ClinicalTrials.gov with Planned Parenthood League of Massachusetts as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Human Chorionic Gonadotropin (hCG) Trend After Medication Abortion: A Prospective Physiologic Study
- Lead sponsor
- Planned Parenthood League of Massachusetts
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2014
- Completion date
- March 31, 2015
- Enrollment
- 66 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
undesired pregnancy